“A lot of the great breakthroughs in America have come from people that immigrated,” said the Swedish Jewish doctor turned pharmaceutical industry leader. (JTA) — When Mikael Dolsten, the ...
Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor. Dolsten’s ...
While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...
Hosted on MSN1mon
Pfizer names head of oncology as new R&D chiefHis appointment follows an internal and external executive search process aimed at replacing Pfizer's (NYSE:PFE) former science chief, Mikael Dolsten, who is ending an over 15-year-long career at ...
Hosted on MSN2mon
Pfizer names oncology chief and company veteran Boshoff as chief scientific officerPfizer Inc. named oncology chief and company veteran Chris Boshoff as its new chief scientific officer on Wednesday, replacing Mikael Dolsten starting Jan. 1. The drug company had been searching ...
He is replacing Dr Mikael Dolsten whose departure from Pfizer was announced in July, bringing a 15-year-plus career at the pharma group to a close, effective 1st January. The shake-up in Pfizer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback